Intermediate Risk Prostate Cancer Published 2023-09-11 Download video MP4 360p Recommendations 13:22 What Happens if You Don't Treat Prostate Cancer? with Dr. Michael Ahdoot 19:55 Gleason 3+4 Prostate Cancer 16:43 High-Risk Prostate Cancer 08:58 How to survive prostate cancer with Brachytherapy or seed radiation 23:20 Intermediate-Risk Prostate Cancer Treatment - MUSC Hollings 30:59 The Complete Guide to SBRT for Prostate Cancer | Amar Kishan, MD, UCLA 28:23 Understanding Prostate Cancer - Intermediate Risk 1:03:54 Radiotherapy for Unfavorable Intermediate Prostate Cancer w/ Dr. Neil Desai | BackTable Ep. 41 21:23 Low-Risk Prostate Cancer Treatment - MUSC Hollings 19:08 Hormone Therapy & Side Effects For High-Risk (Gleason 8) #ProstateCancer | Mark Scholz, MD #PCRI 13:47 49: Active Surveillance for Low-Risk Prostate Cancer with Laurence Klotz, M.D. 36:55 Ep. 22 - Is SBRT (Cyberknife) a Good Treatment for Prostate Cancer? 39:50 Risks Of ADT in Recurrent Prostate Cancer 51:29 Radiation Therapy for Favorable Intermediate Risk Prostate Cancer w/ Dr. Amar Kishan | Ep. 53 50:36 What they don't tell you about Androgen Deprivation Therapy (ADT, hormone therapy) 21:24 Navigating #ProstateCancer: Expert Tips on Choosing the Best Prostate Cancer Care | #MarkScholzMD 17:31 Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer– Brachytherapy 03:32 Active Surveillance for Prostate Cancer 16:26 6 Days Post Prostate Cancer Surgery - Prostatectomy Recovery Feb 2021 49:19 Active Surveillance for Prostate Cancer How to's Similar videos 14:06 Intermediate-Risk: Do You Need Hormone Therapy With Radiation? | #MarkScholzMD #AlexScholz #PCRI 01:42 Active surveillance or intervention in intermediate-risk prostate cancer 07:44 Choosing a Treatment for Intermediate Risk Prostate Cancer | Prostate Cancer Staging Guide 02:57 Role of genomic profiling in the management of intermediate-risk prostate cancer 05:54 Determining How Aggressively to Treat Relapsed & Intermediate-Risk Prostate Cancer | Mark Scholz, MD 11:13 Active Surveillance in Favorable Intermediate-Risk Prostate Cancer 02:00 Intermediate Risk Prostate Cancer: Felix Feng, MD 01:37 Intermediate Risk Prostate Cancer: Omar Mian, MD, PhD 06:11 "Controversial" role of androgen deprivation therapy in intermediate-risk prostate cancer 04:36 An Overview of Gleason 3+4 & Gleason 4+3 Prostate Cancer | Ask A Prostate Expert, Mark Scholz, MD 18:53 Focal Therapy for Men with Intermediate Risk Prostate Cancer 06:42 Low Risk (Gleason 3+3=6) & Intermediate Risk (Gleason 3+4=7) Prostate Cancer Q+A | PCRI #13 09:15 Point-Counterpoint: Active Surveillance for Intermediate-Risk Prostate Cancer - Pro 06:46 Proton Therapy Intermediate-Risk (Teal) Prostate Cancer | Prostate Cancer Staging Guide 02:22 Intermediate Risk Prostate Cancer: Paul Nguyen, MD 36:14 Applying a Clinical Genomic Nomogram for ADT Decisions in Intermediate Risk Prostate Cancer 09:44 Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer - Surgery 30:06 Intermediate and "High-Risk" Prostate Cancer - 2019 Prostate Cancer Patient Conference More results